Class Effects and Labeling of Antihypertensive Drugs-Reference-Cited by-同舟云学术

Class Effects and Labeling of Antihypertensive Drugs

Published:2006-03 Issue:3 Volume:8 Page:215-220
ISSN:1524-6175
Container-title:The Journal of Clinical Hypertension
language:en
Short-container-title:The Journal of Clinical Hypertension

Author:

Pickering Thomas G.¹

Affiliation:

1. From the Behavioral Cardiovascular Health and Hypertension Program, Columbia Presbyterian Medical Center, New York, NY

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1524-6175.2005.05122.x

Reference39 articles.

1. Health Outcomes Associated With Various Antihypertensive Therapies Used as First-Line Agents

2. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

3. Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

4. Heart Outcomes Prevention Evaluation Study Investigators;Effects of an angiotensin‐converting‐enzyme inhibitor, ramipril, on cardiovascular events in high risk patients;N Engl J Med,2000

5. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis and evaluation of 9-hydroxy-7H-furo[3,2-g]chromen-7-one derivatives as new potential vasodilatory agents;Journal of Asian Natural Products Research;2014-01-08

2. What can we do to make antihypertensive medications taste better for children?;International Journal of Pharmaceutics;2013-11

3. Nephrogenic Systemic Fibrosis and Class Labeling of Gadolinium-based Contrast Agents by the Food and Drug Administration;Radiology;2012-10